ArticleCancer gene therapy2025

Characterization of tertiary lymphoid structure identifies competitive binding of CD40 and STING with TRAF2 driving IRF4-mediated B cell activation in esophageal squamous cell carcinoma.

Yujia Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.